There are plenty of complex biochemical mechanisms underlying TAM resistance in cancer cells, as reported ERα levels in resistant cells are lower than in normal BC cells, and the hypoxic tumor microenvironment has long been linked to resistance [6]. This evidence concerns the gene ESR1 and breast cancer.